Author: Charmaine Fraser

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contract with its valued and long-standing client, Numab Therapeutics AG.   This latest project will use modelling and simulation approaches to support the pre-clinical development of a multi-specific antibody in the Numab Therapeutics pipeline, under development for the...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contract in the biometrics department with a new client, GARDP Foundation (“GARDP”). GARDP is a not-for-profit research and development organisation that addresses global public health needs by developing new or improved antibiotic treatments, while endeavouring to...

TR-1: Standard form for notification of major holdings Please click here to read in full...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the award of two new modelling and simulation contracts with the total value of £29,750.   Contract Award 1: Physiomics has secured a contract with a UK-based biotech firm specialising in AI-powered drug development. Building on an earlier projects announced...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biometrics company supporting the development of new therapeutics and personalised medicine solutions, announces that Peter Sargent will be stepping down from his role as Executive Director and CEO of the Company to pursue other opportunities, with effect from 29 May 2026.   The Company has commenced its search to appoint a new CEO and further announcements...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biometrics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that all resolutions put to shareholders at the Company’s annual general meeting, held earlier today, were duly passed. Voting was conducted by a show of hands and inclusive of votes received by the Company by way of proxy.   Click...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biometrics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to provide notice of the Company’s Annual General Meeting (“AGM”).   The AGM will be held at 10.30 a.m. on 18 November 2025 at Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, OX14 4SB.   Shareholders will shortly be sent either printed copies of...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that, effective from 1 October 2025, its registered office will change to Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, OX14 4RY. For more information about Physiomics and its services, please visit www.physiomics.co.uk.     Enquiries:   Physiomics plc Dr Peter Sargent, CEO +44 (0)1235 841575   Hybridan...